4//SEC Filing
Brown Cabot 4
Accession 0000899243-21-000787
CIK 0001351288other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:31 PM ET
Size
9.5 KB
Accession
0000899243-21-000787
Insider Transaction Report
Form 4
Brown Cabot
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2021-01-04$0.00/sh+3,576$5→ 10,776 total - Exercise/Conversion
Share Options
2021-01-04+3,576→ 4 totalExercise: $0.00From: 2021-01-04Exp: 2021-01-04→ Ordinary Shares (3,576 underlying) - Tax Payment
Ordinary Shares
2021-01-04$9.62/sh−1,440$13,853→ 9,336 total
Footnotes (6)
- [F1]Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
- [F2]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.37 U.S. Dollars as of January 4, 2020.
- [F3]Excluding 9,868 ordinary shares underlying RSU-style share options previously reported in Column 5 of Table I, of which 3,580 ordinary shares vested on January 4, 2021 and 6,288 ordinary shares have not vested. Excluding 20 ordinary shares erroneously included in Column 5 of Table I of previous form 4s.
- [F4]Mandatory withhold to cover vested RSU style share options.
- [F5]Represented by ADS.
- [F6]The price reported is price per ordinary share converted from price per ADS.
Documents
Issuer
GW PHARMACEUTICALS PLC
CIK 0001351288
Entity typeother
Related Parties
1- filerCIK 0001754153
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:31 PM ET
- Size
- 9.5 KB